Table 3.

Biochemical indices measure after three-month run-in period, median (range), mg/dL.

	Danshen group (n = 63)	Placebo group (n = 63)	P values
Lipid profile
LDL cholesterol	113 (90–147)	120 (91–150)	0.324
HDL cholesterol	55 (44–68)	51 (47–65)	0.512
Total cholesterol	190 (172–234)	189 (176–248)	0.763
Triglycerides	114 (87–173)	118 (82–166)	0.262
Apolipoprotein A	98 (82–126)	99 (85–128)	0.899
Apolipoprotein B	76 (66–103)	78 (62–109)	0.842
Apolipoprotein E	7.0 (5.8–8.5)	7.2 (5.4–8.8)	0.763
Lipoprotein (a)	32 (22–45)	34 (25–48)	0.268
Liver function
Gamma-glutamyl transpeptidase (IU/dL)	3.3 (2.5–5.4)	3.1 (2.5–5.3)	0.275
Total bilirubin	0.5 (0.4–0.7)	0.6 (0.4–0.8)	0.431
Indirect bilirubin	0.5 (0.3–0.5)	0.4 (0.3–0.5)	0.176
Direct bilirubin	0.4 (0.2–0.6)	0.4 (0.2–0.5)	0.185
Renal function
Uric acid	5.1 (4.2–6.8)	5.3 (4.2–6.4)	0.267
Risk factor of heart disease
Homocysteine	23 (20–43)	25 (20–46)	0.341